That's essential, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (second wave). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development practically nobody discovered. However it's going to have profound implications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of financial investment opportunities in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (future report). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back possibly substantially prior to going greater - future report review. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown 2021 stock picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous great private companies on the verge of hitting the public markets And I've been working on a new method for you to invest even before these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to schedule your spot for complimentary.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (self-driving cars). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (bleeding edge). In truth, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and producing extraordinary chances for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown predictions 2021. However in spite of what many readers might think, this is a trend that's simply getting started. Although the COVID-19 pandemic interrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (biotech stock). Losing two months of manufacturing and sales actually affects how many 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million systems is exceptional. More importantly, the delays brought on by the pandemic produced a lots of bottled-up need. And that need is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown genome sequencing stock. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually described its three different stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services start to be offered (toxic tech 5 tech darlings). That's when we start to see applications running on 5G networks. Believe of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of people don't truly care about the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well understood. And throughout that time, there were really just 3 companies running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole market is efficiently a greenfield chance.
There's room for many business to exist in this space. united arab emirates. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can properly anticipate the folding of a protein based solely on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental procedure. But now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced using this technology. This was among those breakthroughs that practically nobody noticed. However it's going to have profound implications for treating illness. And, naturally, there will be a lot of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly significantly prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - biotech stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown prediction for 2021. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date as of February 2021, but we could not independently confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to pick winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent perspective on the market. He's always on the hunt for new chances, and he shares a number of his best picks in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated a few of the greatest financial occasions of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right each time, however Jeff Brown's precise predictions have earned him legions of devoted fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent financial research publisher. Brownstone Research study offers several research study services with a wide range of specializations - brownstone research.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown top stock pick 2021. On its website, Brownstone states its mission is to provide retail financiers with professional-grade research: "For too long, the finest investment research study has not been readily available to specific financiers. It has actually been normally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown top stock pick 2021. The mission of Brownstone Research study is to make that sort of exclusive research offered to any financiers wanting to gain an edge in the markets. The goal is basic to provide special and successful financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. tech stock. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown believes S.A.V. angel investor. could be "the biggest pattern of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 innovative innovations: synthetic intelligence and electric cars. Musk hopes the combination will help him develop the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you understand, electric lorries and self-driving car stocks have actually been substantial this year, however the Wall Street maker has actually approved buzz without much concrete result. Regardless of an extreme boost in competition over the previous few years, Brown still thinks Musk has the very best chance of putting all of it together.
tech might be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this technology would enable you to rent your cars and truck as a self-governing, self-driving taxi when you're not using it. You just get out of the car and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large portion of the profits. It sounds ridiculous, however it could be closed than you believe.